HH Biotechnology Holdings Co (HHBT) Financial Statements
HH Biotechnology Holdings Co Financial Overview
HH Biotechnology Holdings Co's market cap is currently $1.41K. The company's EPS TTM is ―; its P/E ratio is 0.00; HH Biotechnology Holdings Co has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 15 | Dec 14 | Dec 13 | Dec 12 | Dec 11 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 2.37M | $ 1.70M | $ 1.24M | $ 1.06M | $ 932.01K |
| Operating Income | $ 3.10M | $ -2.77M | $ -656.49K | $ -913.77K | $ -1.12M |
| EBITDA | $ 6.75M | $ 1.08M | $ 3.00M | $ 3.08M | $ 3.46M |
| Net Income | $ 2.48M | $ -4.31M | $ -1.81M | $ -2.33M | $ 3.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 46.46M | $ 53.98M | $ 59.56M | $ 59.43M | $ 61.41M |
| Total Debt | $ 4.63M | $ 21.24M | $ 21.77M | $ 21.16M | $ 20.94M |
| Net Debt | $ -5.19M | $ 12.44M | $ 14.66M | $ 15.23M | $ 14.65M |
| Total Liabilities | $ 18.10M | $ 34.85M | $ 35.54M | $ 34.31M | $ 34.18M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ 3.53M | $ 1.69M | $ 1.68M | $ 753.51K | $ 1.59M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
